Figure 1 AIT in asthma: benefits, research gaps and immunological
mechanisms
1. Agache I, Lau S, Akdis CA, Smolinska S, Bonini M, Cavkaytar O, et al.
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven
allergic asthma. Allergy. 2019;74(5):855-73.
2. Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, et al.
Allergen immunotherapy for allergic asthma: A systematic review and
meta-analysis. Allergy. 2017;72(12):1825-48.
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic
vaccines for allergic diseases. A WHO position paper. J Allergy Clin
Immunol. 1998;102(4 Pt 1):558-62.
4. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Mechanisms of
Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual
Immunotherapy. Immunol Allergy Clin North Am. 2016;36(1):71-86.
5. Komlosi ZI, Kovacs N, Sokolowska M, van de Veen W, Akdis M, Akdis CA.
Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy:
What Is New? Immunol Allergy Clin North Am. 2020;40(1):1-14.
6. Calderon MA, Vidal C, Rodriguez Del Rio P, Just J, Pfaar O, Tabar AI,
et al. European Survey on Adverse Systemic Reactions in Allergen
Immunotherapy (EASSI): a real-life clinical assessment. Allergy.
2017;72(3):462-72.
7. Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, et al.
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet
in Adults With Allergic Asthma: A Randomized Clinical Trial. JAMA.
2016;315(16):1715-25.
8. Global Initiative for Asthma. Global strategy for asthma management
and prevention 2020 [Available from:
www.ginasthma.org. Accessed 30 June
2021)
9. Rosewich M, Girod K, Zielen S, Schubert R, Schulze J. Induction of
Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted
Specific Immunotherapy in Children With Grass Pollen Allergies. Allergy
Asthma Immunol Res. 2016;8(3):257-63.
10. Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma.
Cochrane Database Syst Rev. 2020;9:CD011293.
11. Asaria M, Dhami S, van Ree R, Gerth van Wijk R, Muraro A, Roberts G,
et al. Health economic analysis of allergen immunotherapy for the
management of allergic rhinitis, asthma, food allergy and venom allergy:
A systematic overview. Allergy. 2018;73(2):269-83.